The Hidden Infrastructure Behind Lower Drug Prices
When drug prices dominate headlines, the conversation inevitably turns to policy: patents, regulation, negotiation authority. These debates matter, but they obscure a less visible truth: the operational infrastructure that determines whether affordable alternatives ever reach the market. The price of a drug reflects more than its development cost or market exclusivity. It reflects the efficiency—or dysfunction—of the systems that bring competing products to patients. When those systems break down, delays compound, competition stalls, and high prices persist long after they should have fallen. The Supply Chain Behind Clinical Trials Before a drug reaches pharmacy shelves, it moves through a clinical trial supply chain that most patients never see. This infrastructure includes manufacturing sites that produce investigational products, distribution networks that deliver them to trial sites, and quality systems that ensure every dose meets regulatory standards. Each clinical trial re...